Prevalence Of Pulmonary Embolism In Patients With HEmoptysis (POPEIHE)

CompletedOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

April 30, 2023

Study Completion Date

August 30, 2023

Conditions
HemoptysisPulmonary Embolism
Interventions
DIAGNOSTIC_TEST

pulmonary embolism diagnosis

"The diagnosis of pulmonary embolism will be made using the diagnostic algorithm suggested by the 2019 European guidelines . The pre-test clinical probability of pulmonary embolism will be defined based on the simplified Wells score. In patients with a low pre-test clinical probability and a D-dimer level below the threshold value the diagnosis of pulmonary embolism will be excluded. The D-dimer level will be measured using the quantitative assay routinely used in each participating center; the threshold value for a positive result compared to a negative result is 500 μg per milliliter for patients under 50 years of age. For each additional decade of age, the exclusion cutoff will increase by 100 μg per milliliter.~The criterion for the presence of pulmonary embolism is the detection of an intraluminal filling defect on CT."

Trial Locations (1)

Unknown

AOU Careggi, Florence

All Listed Sponsors
lead

Società Italiana di Medicina di Emergenza-Urgenza

OTHER

NCT06067997 - Prevalence Of Pulmonary Embolism In Patients With HEmoptysis (POPEIHE) | Biotech Hunter | Biotech Hunter